These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 21374800

  • 1. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
    Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E.
    Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
    [Abstract] [Full Text] [Related]

  • 2. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
    Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E.
    Carcinogenesis; 2006 Apr; 27(4):811-9. PubMed ID: 16280330
    [Abstract] [Full Text] [Related]

  • 3. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
    Myzak MC, Karplus PA, Chung FL, Dashwood RH.
    Cancer Res; 2004 Aug 15; 64(16):5767-74. PubMed ID: 15313918
    [Abstract] [Full Text] [Related]

  • 4. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
    Rajendran P, Delage B, Dashwood WM, Yu TW, Wuth B, Williams DE, Ho E, Dashwood RH.
    Mol Cancer; 2011 May 30; 10():68. PubMed ID: 21624135
    [Abstract] [Full Text] [Related]

  • 5. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
    Herman-Antosiewicz A, Xiao H, Lew KL, Singh SV.
    Mol Cancer Ther; 2007 May 30; 6(5):1673-81. PubMed ID: 17513615
    [Abstract] [Full Text] [Related]

  • 6. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
    Ho E, Clarke JD, Dashwood RH.
    J Nutr; 2009 Dec 30; 139(12):2393-6. PubMed ID: 19812222
    [Abstract] [Full Text] [Related]

  • 7. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
    Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW.
    Int J Oncol; 2004 Jan 30; 24(1):187-92. PubMed ID: 14654956
    [Abstract] [Full Text] [Related]

  • 8. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells.
    Cho SD, Li G, Hu H, Jiang C, Kang KS, Lee YS, Kim SH, Lu J.
    Nutr Cancer; 2005 Jan 30; 52(2):213-24. PubMed ID: 16201852
    [Abstract] [Full Text] [Related]

  • 9. Multi-targeted prevention of cancer by sulforaphane.
    Clarke JD, Dashwood RH, Ho E.
    Cancer Lett; 2008 Oct 08; 269(2):291-304. PubMed ID: 18504070
    [Abstract] [Full Text] [Related]

  • 10. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity.
    Jiang LL, Zhou SJ, Zhang XM, Chen HQ, Liu W.
    Biomed Pharmacother; 2016 Mar 08; 78():74-80. PubMed ID: 26898427
    [Abstract] [Full Text] [Related]

  • 11. The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses.
    Dickinson SE, Rusche JJ, Bec SL, Horn DJ, Janda J, Rim SH, Smith CL, Bowden GT.
    Mol Carcinog; 2015 Nov 08; 54(11):1513-20. PubMed ID: 25307283
    [Abstract] [Full Text] [Related]

  • 12. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.
    Thakur VS, Gupta K, Gupta S.
    Carcinogenesis; 2012 Feb 08; 33(2):377-84. PubMed ID: 22114073
    [Abstract] [Full Text] [Related]

  • 13. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells.
    Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC.
    Int J Oncol; 2002 Mar 08; 20(3):631-6. PubMed ID: 11836580
    [Abstract] [Full Text] [Related]

  • 14. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.
    Nian H, Delage B, Ho E, Dashwood RH.
    Environ Mol Mutagen; 2009 Apr 08; 50(3):213-21. PubMed ID: 19197985
    [Abstract] [Full Text] [Related]

  • 15. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.
    Beaver LM, Yu TW, Sokolowski EI, Williams DE, Dashwood RH, Ho E.
    Toxicol Appl Pharmacol; 2012 Sep 15; 263(3):345-51. PubMed ID: 22800507
    [Abstract] [Full Text] [Related]

  • 16. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
    Abbas A, Hall JA, Patterson WL, Ho E, Hsu A, Al-Mulla F, Georgel PT.
    Biochem Cell Biol; 2016 Feb 15; 94(1):71-81. PubMed ID: 26458818
    [Abstract] [Full Text] [Related]

  • 17. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, Puccio GM, Feng J, Liu D, Chiao JW.
    Int J Oncol; 2008 Aug 15; 33(2):375-80. PubMed ID: 18636159
    [Abstract] [Full Text] [Related]

  • 18. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.
    Wong CP, Hsu A, Buchanan A, Palomera-Sanchez Z, Beaver LM, Houseman EA, Williams DE, Dashwood RH, Ho E.
    PLoS One; 2014 Aug 15; 9(1):e86787. PubMed ID: 24466240
    [Abstract] [Full Text] [Related]

  • 19. Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.
    Zhang Z, Garzotto M, Davis EW, Mori M, Stoller WA, Farris PE, Wong CP, Beaver LM, Thomas GV, Williams DE, Dashwood RH, Hendrix DA, Ho E, Shannon J.
    Nutr Cancer; 2020 Aug 15; 72(1):74-87. PubMed ID: 31155953
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells.
    Beklemisheva AA, Fang Y, Feng J, Ma X, Dai W, Chiao JW.
    Anticancer Res; 2006 Aug 15; 26(2A):1225-30. PubMed ID: 16619528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.